rs3025058 — MMP3 5A/6A

The Matrix Remodeler — How a Promoter Variant Shapes Your Joints and Arteries

Matrix metalloproteinase-3 (MMP-3), also called stromelysin-1, is one of the body's primary enzymes for breaking down the extracellular matrix — the structural scaffolding that holds tissues together. MMP-3 degrades collagen types II, III, IV, IX, and X, along with proteoglycans, fibronectin, laminin, and elastin¹¹ MMP-3 degrades collagen types II, III, IV, IX, and X, along with proteoglycans, fibronectin, laminin, and elastin
These proteins form the framework of cartilage, tendons, blood vessel walls, and other connective tissues. The rs3025058 polymorphism, a simple insertion or deletion of a single adenosine base in the gene's promoter region at position -1612, profoundly affects how much MMP-3 your cells produce.

The variant is known as the 5A/6A polymorphism because one version contains a run of 5 adenosines (the 5A allele, higher activity) while the other has 6 adenosines (the 6A allele, lower activity). In 23andMe raw data, this appears as T's on the complementary strand: TT corresponds to 5A/5A (highest MMP-3 expression), CT to 5A/6A (intermediate), and CC to 6A/6A (lowest expression).

The Mechanism

This is a classic example of a regulatory variant — the DNA sequence change doesn't alter the MMP-3 protein itself, but rather controls the dimmer switch determining how much enzyme gets made. The 5A allele shows 2-4 fold higher promoter activity and gene expression compared to the 6A allele²² The 5A allele shows 2-4 fold higher promoter activity and gene expression compared to the 6A allele
Studies in macrophages, smooth muscle cells, and fibroblasts all demonstrate this functional difference. The mechanism involves differential binding of the transcription factor NFκB: the NFκB p50 and p65 subunits bind more strongly to the 5A allele than the 6A allele, particularly during inflammatory conditions³³ the NFκB p50 and p65 subunits bind more strongly to the 5A allele than the 6A allele, particularly during inflammatory conditions
This allele-specific transcriptional regulation is augmented when cells are activated.

The Evidence

The clinical consequences of this promoter polymorphism depend heavily on context — which tissue is affected, what type of stress it's under, and even ancestry. The most robust associations emerge in musculoskeletal conditions:

Osteoarthritis and Joint Degeneration: A meta-analysis in Chinese men found multiple MMP-3 SNPs associated with increased osteoarthritis risk⁴⁴ A meta-analysis in Chinese men found multiple MMP-3 SNPs associated with increased osteoarthritis risk
rs3025058 was among the variants showing significant association. The biology makes sense: excessive MMP-3 activity accelerates cartilage breakdown, while insufficient activity impairs the normal remodeling needed for joint health. Studies in rheumatoid arthritis patients found those homozygous for the 6A allele had significantly more radiographic damage and higher serum MMP-3 levels⁵⁵ Studies in rheumatoid arthritis patients found those homozygous for the 6A allele had significantly more radiographic damage and higher serum MMP-3 levels
The 6A/6A genotype was associated with a Larsen score of 109.8 vs 91.1 for other genotypes.

Tendon and Ligament Injury: A 2022 meta-analysis of 2,871 cases and 4,497 controls found rs3025058 associated with increased tendon-ligament injury risk in Caucasians and Brazilians⁶⁶ A 2022 meta-analysis of 2,871 cases and 4,497 controls found rs3025058 associated with increased tendon-ligament injury risk in Caucasians and Brazilians
This included Achilles tendinopathy, ACL rupture, tennis elbow, and rotator cuff tears. MMP-3 normally maintains healthy collagen turnover in tendons, but dysregulated expression — whether too high or too low — can predispose to injury under mechanical stress.

Cardiovascular Disease: The picture is more complex here, with ancestry-specific effects. In a large meta-analysis combining 15 studies with 10,061 cases and 8,048 controls, the 5A allele showed reduced coronary disease risk in Europeans (OR 0.87) but increased risk in East Asian populations⁷⁷ In a large meta-analysis combining 15 studies with 10,061 cases and 8,048 controls, the 5A allele showed reduced coronary disease risk in Europeans (OR 0.87) but increased risk in East Asian populations
The overall analysis found no consistent association. However, within European cohorts, the 6A/6A genotype was associated with greater numbers of coronary arteries with significant stenosis (OR 1.52), while the 5A allele carriers showed increased myocardial infarction risk (OR 1.78-2.02)⁸⁸ the 6A/6A genotype was associated with greater numbers of coronary arteries with significant stenosis (OR 1.52), while the 5A allele carriers showed increased myocardial infarction risk (OR 1.78-2.02)
This suggests different disease processes: stable but bulky plaques in 6A/6A individuals vs unstable rupture-prone plaques in 5A carriers.

Other Associations: The variant has also been linked to colonic diverticulosis⁹⁹ colonic diverticulosis
5A/5A genotype nearly twice as common in patients vs controls, abdominal aortic aneurysm¹⁰¹⁰ abdominal aortic aneurysm
5A allele associated with increased risk, and earlier age at Alzheimer's disease onset in 5A/6A heterozygotes¹¹¹¹ earlier age at Alzheimer's disease onset in 5A/6A heterozygotes.

Practical Implications

Your MMP-3 genotype interacts with mechanical stress, inflammation, and aging to influence connective tissue health. The "optimal" genotype likely depends on your specific risk factors and tissue demands. High MMP-3 expression (TT/5A5A) accelerates matrix turnover — beneficial when you need tissue remodeling, potentially harmful when sustained inflammation drives excessive degradation. Low MMP-3 expression (CC/6A6A) preserves existing matrix but may impair adaptation to mechanical demands or clearance of damaged proteins.

For joint health, this means paying attention to the balance between loading and recovery. MMP-3 expression is activated by inflammatory cytokines like IL-1 and TNF-α¹²¹² MMP-3 expression is activated by inflammatory cytokines like IL-1 and TNF-α
Chronic low-grade inflammation amplifies genotype effects. If you carry genotypes associated with joint degeneration in your ancestry group, anti-inflammatory lifestyle factors become especially important: maintaining healthy body weight to reduce joint loading, omega-3 fatty acids to dampen inflammatory signaling, and strength training to build muscular support around vulnerable joints.

For tendon injury risk, progressive loading becomes critical. If you're ramping up training volume or starting a new athletic activity, the principle of gradual adaptation matters more than for those with protective genotypes. Allow adequate recovery time between high-stress sessions, and prioritize technique over intensity — proper movement patterns distribute forces more evenly across connective tissues.

Interactions

MMP-3 works within a broader network of matrix metalloproteinases and their inhibitors. Other MMP-3 gene variants (rs679620, rs650108, rs520540, rs602128) may interact with rs3025058 to influence net enzyme activity and tissue remodeling capacity. Studies in ACL rupture found that MMP3 rs679620 may interact with MMP10 rs485055, MMP1 rs1799750, and MMP12 rs2276109 to collectively contribute to injury susceptibility¹³¹³ Studies in ACL rupture found that MMP3 rs679620 may interact with MMP10 rs485055, MMP1 rs1799750, and MMP12 rs2276109 to collectively contribute to injury susceptibility
These multi-locus effects suggest pathway-level interactions. The balance between MMPs and tissue inhibitors of metalloproteinases (TIMPs) ultimately determines whether you're in a net catabolic (breakdown) or anabolic (building) state in your connective tissues.